Obstructive Lung Diseases Completed Phase 2 Trials for Ipratropium (DB00332)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00117182Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPDDiagnostic